Exact Mass: 558.0400390000001
Exact Mass Matches: 558.0400390000001
Found 29 metabolites which its exact mass value is equals to given mass value 558.0400390000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
6-({5,7-dihydroxy-2-[4-hydroxy-3-(sulfooxy)phenyl]-4-oxo-4H-chromen-3-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
8-Hydroxyluteolin 4'-methyl ether 8-glucoside-3'-sulfate
C22H22O15S (558.0679382000001)
8-Hydroxyluteolin 4-methyl ether 8-glucoside-3-sulfate is found in herbs and spices. 8-Hydroxyluteolin 4-methyl ether 8-glucoside-3-sulfate is isolated from Althaea officinalis (marsh mallow) (as K salt).
(2S,3S,4S,5R)-6-[2-(3,4-Dihydroxyphenyl)-7-hydroxy-4-oxo-3-sulfooxychromen-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
Tamarixetin 3-glucoside-7-sulfate
C22H22O15S (558.0679382000001)
Quercetin 3-methyl ether 5-glucoside-3-sulfate
C22H22O15S (558.0679382000001)
hypolaetin 8-O-beta-D-glucuronopyranoside 3-O-sulfate|theograndin II
8-Hydroxyluteolin 4-methyl ether 8-glucoside-3-sulfate
C22H22O15S (558.0679382000001)
2,6-Dibromo-4,4-bis(2-ethylhexyl)-4H-cyclopenta[2,1-b:3,4-b]dithiophene
2,6-Dibromo-4,4-dioctyl-4H-cyclopenta[1,2-b:5,4-b]dithiophene
5-BroMo-4-chloro-3-indolyl-α-D-N-acetylneuraMinic acid sodiuM salt
C19H21BrClN2NaO9 (558.0016586)
Ertiprotafib
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent Ertiprotafib is an inhibitor of PTP1B, IkB kinase β (IKK-β), and a dual PPARα and PPARβ agonist, with an IC50 of 1.6 μM for PTP1B, 400 nM for IKK-β, an EC50 of ~1 μM for PPARα/PPARβ.
Theograndin II
A glycosyloxyflavone and a monosaccharide sulfate that is the 8-O-beta-D-glucuronopyranoside-3-O-sulfate derivative of hypolaetin. It has been isolated from the seeds of Theobroma grandiflorum and has been shown to exhibit antioxidant activity.
6-[5,7-Dihydroxy-2-(4-hydroxy-3-sulooxyphenyl)-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
[[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl phosphate
C15H20N4O15P2-2 (558.0400390000001)
(2S,3S,4S,5R)-6-[2-(3,4-Dihydroxyphenyl)-7-hydroxy-4-oxo-3-sulfooxychromen-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
Hydrogen (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetato(4-))gadolinate(1-)
V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media D064449 - Sequestering Agents > D002614 - Chelating Agents
7-Phenyl-5-(4-sulfoanilino)benzo[a]phenazin-7-ium-3-sulfonic acid
C28H20N3O6S2+ (558.0793480000001)
(1's,2r,3r,8'r,10'r,11'r,14'r)-11'-chloro-10',14'-dihydroxy-6,7-dimethoxy-6'-methyl-3,8'-bis(methylsulfanyl)-3h-2'-oxa-3',6'-diazaspiro[1-benzofuran-2,5'-tricyclo[8.4.0.0³,⁸]tetradecan]-12'-ene-4',7'-dione
C23H27ClN2O8S2 (558.0897292000001)
n-[2-(acetyloxy)ethyl]-6-[2-(6-chloroquinolin-2-yl)-1,3-thiazol-4-yl]-5-methoxy-1-methyl-3-(methylsulfanyl)-4-oxopyridine-2-carboximidic acid
C25H23ClN4O5S2 (558.0798338000001)